title: Response of hemophilia A with bleeding to fresh dry plasma.
abstract: Fresh dry plasma (FDP) is a lyophilized form of fresh frozen plasma (FFP) which can be stored at 4 degrees C for one year. One bottle of FDP is prepared from 220 ml of FFP and contains FVIII: C 0.75 +/- 0.3 U/ml (mean +/- 1 SD). This study describes the clinical and laboratory response in 7 severe and 4 moderate hemophilia A patients. The age ranged from 7-17 years (mean +/- SD = 11.7 +/- 2.9 years). Either 12.4 ml/kg. FDP or 12.2 ml/kg FFP was transfused to the patients when they had bleeding episodes such as hemarthrosis, hematoma. 16 episodes of FDP and 12 episodes of FFP transfusion were studied. The bleeding could be effectively controlled by FDP or FFP except one patient who had physical therapy at 8 hours post FDP transfusion. The increment of FVIII:C was 14.1 +/- 5.3% at 30 minutes after FDP transfusion and 12.1 +/- 3.7% at 30 minutes after FFP transfusion. The recovery rate was 83.2 +/- 32.6% in FDP and 65.3 +/- 22.7% in FFP transfusion. The FVIII:C was decreased to 78.9 +/- 12.3%, 55.6 +/- 13% and 16.3% of the initial level at 2, 8, 24 hours after FDP transfusion respectively which were not statistically significantly different from FFP transfusion. No serious complication was found. FDP will replace FFP for the treatment of coagulation disorders such as hemophilia A. It is an useful alternative therapy which can be provided to the hemophiliac patients in the rural area in developing countries.
authors.affiliation: Department of Pediatrics, Pramongkutklao Hospital, Bangkok, Thailand.
authors.forename: T
authors.initials: T
authors.lastname: Krutvacho
authors.forename: A
authors.initials: A
authors.lastname: Chuansumrit
authors.forename: P
authors.initials: P
authors.lastname: Isarangkura
authors.forename: P
authors.initials: P
authors.lastname: Pintadit
authors.forename: P
authors.initials: P
authors.lastname: Hathirat
authors.forename: P
authors.initials: P
authors.lastname: Chiewsilp
mesh_terms: D000293:Adolescent; D002648:Child; D017742:Dental Care for Chronically Ill; D005169:Factor VIII / Q000627:therapeutic use; D005612:Freeze Drying; D006467:Hemophilia A / Q000150:complications*; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy*; D006801:Humans; D010949:Plasma; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D005169:Factor VIII